Actinogen Medical Limited ACN 086 778 476 Suite 901, Level 9, 109 Pitt Street, Syd n ey NSW 2000 +61 2 8964 7401 | actinogen.com.au 1 ASX ANNOUNCEMENT ACW Clinical Trials Science Forum webinar today – The future of Alzheimer’s disease treatment Sydney, 12 August 2026....
ACW webinar today, The future of Alzheimers treatment
Filed with ASX · · 18 pages · English
Summary by 6ix AI
Actinogen Medical Limited has announced a webinar titled 'The future of Alzheimer’s disease treatment' scheduled for today, which aims to provide insights into evolving diagnostic and therapeutic approaches for Alzheimer's disease. The webinar will feature discussions moderated by the Chief Commercial Officer and include expert perspectives from a renowned neurologist and the Chief Medical Officer of Actinogen. This event is intended for investors and stakeholders to understand the current landscape of Alzheimer's treatment and the potential impact of new therapies.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- Updated Securities Trading Policy
- Application for quotation of securities - ACW
- Notification of cessation of securities - ACW
- ACW Bioshares presentation, strong cortisol rationale
- ACW webinar on the future of Alzheimers treatment
Later from Actinogen Medical
- Appendix 3Y-Malcolm McComas
- Appendix 3Y - Dr George Morstyn
- Corporate Governance Statement
- Appendix 4G
- ACW Appendix 4E and 2026 annual report
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical